Stage III Multiple Myeloma: 437 Clinical Trials, Page 3 of 44

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:September 23, 2022Active, not recruiting

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:June 26, 2015Terminated

Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:September 13, 2019Completed

Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:April 24, 2015Withdrawn

Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:November 29, 2017Terminated

Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:September 17, 2018Completed

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:June 2, 2014Completed

Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma

Condition(s):Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:October 8, 2013Terminated

Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

Condition(s):Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:September 30, 2013Completed

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Condition(s):Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell NeoplasmLast Updated:July 10, 2013Withdrawn

«1 2 3 4 5 …10 15 20 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.